These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 9034862)
21. Identification of an indirectly presented epitope in a mouse model of skin allograft rejection. MacEachern MC; Burkhart C; Lowrey PA; Wraith DC Transplantation; 1998 May; 65(10):1357-64. PubMed ID: 9625019 [TBL] [Abstract][Full Text] [Related]
22. Class I peptides involved in the indirect pathway of allorecognition. Takemoto SK Clin Transpl; 1997; ():317-35. PubMed ID: 9919415 [TBL] [Abstract][Full Text] [Related]
23. Thymic recognition of class II major histocompatibility complex allopeptides induces donor-specific unresponsiveness to renal allografts. Sayegh MH; Perico N; Imberti O; Hancock WW; Carpenter CB; Remuzzi G Transplantation; 1993 Aug; 56(2):461-5. PubMed ID: 7689263 [TBL] [Abstract][Full Text] [Related]
24. The contribution of MHC antigen modulation to islet allograft rejection. Markmann JF; Schachner MS; Bassiri H; Barker CF; Naji A Horm Metab Res Suppl; 1990; 25():104-8. PubMed ID: 2088947 [No Abstract] [Full Text] [Related]
25. Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides. Fangmann J; Dalchau R; Fabre JW J Exp Med; 1992 Jun; 175(6):1521-9. PubMed ID: 1588278 [TBL] [Abstract][Full Text] [Related]
26. Indirect recognition of donor MHC Class II antigens in human transplantation. Liu Z; Harris PE; Colovai AI; Reed EF; Maffei A; Suciu-Foca N Clin Immunol Immunopathol; 1996 Mar; 78(3):228-35. PubMed ID: 8605698 [TBL] [Abstract][Full Text] [Related]
27. The role of CD30 in skin and heart allograft rejection in the mouse. Beckmann J; Kurts C; Klebba I; Bayer B; Klempnauer J; Hoffmann MW Transplant Proc; 2001; 33(1-2):140-1. PubMed ID: 11266747 [No Abstract] [Full Text] [Related]
28. Mechanisms of human cardiac allograft rejection: absence of co-stimulatory molecules and cell adhesion molecules on major histocompatibility complex class I/II+ human cardiac myocytes does not induce anergy. Sundstrom JB; Mayne A; Kanter K; Herskowitz A; Ansari AA Transplant Proc; 1995 Feb; 27(1):1310-3. PubMed ID: 7878895 [No Abstract] [Full Text] [Related]
29. Indirect allorecognition promotes the development of cardiac allograft vasculopathy. Lee RS; Yamada K; Houser SL; Womer KL; Maloney ME; Rose HS; Sayegh MH; Madsen JC Transplant Proc; 2001; 33(1-2):308-10. PubMed ID: 11266832 [No Abstract] [Full Text] [Related]
30. Specific inhibition of heart allograft rejection by serum from liver-grafted rats. Kamada N; Shinomiya T; Tamaki T Transplant Proc; 1987 Feb; 19(1 Pt 1):570-1. PubMed ID: 3274823 [No Abstract] [Full Text] [Related]
31. Indirect T-cell recognition in human allograft rejection. Suciu-Foca N; Liu Z; Colovai AI; Fisher P; Ho E; Reed EF; Rose EA; Michler RE; Hardy MA; Cocciolo P; Gargano F; Cortesini R Transplant Proc; 1997; 29(1-2 /01):1012-3. PubMed ID: 9123174 [No Abstract] [Full Text] [Related]
32. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies. Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897 [TBL] [Abstract][Full Text] [Related]
33. Role of the major histocompatibility complex class I regions in rat natural killer cell allograft responses in vivo and in vitro. Rolstad B Chem Immunol; 1996; 64():59-76. PubMed ID: 8942072 [No Abstract] [Full Text] [Related]
34. Allograft survival following immunization with membrane-bound or soluble peptide MHC class I donor antigens: factors relevant for the induction of rejection by indirect recognition. Terness P; Dufter C; Otto G; Opelz G Transpl Int; 1996; 9(1):2-8. PubMed ID: 8748404 [TBL] [Abstract][Full Text] [Related]
35. CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II. Pietra BA; Wiseman A; Bolwerk A; Rizeq M; Gill RG J Clin Invest; 2000 Oct; 106(8):1003-10. PubMed ID: 11032860 [TBL] [Abstract][Full Text] [Related]
36. T cells mediating early acute kidney allograft rejection in the rat are different from those responsible for chronic rejection. Braun MY; McCormack A; Webb G; Batchelor JR Transplant Proc; 1993 Feb; 25(1 Pt 2):863-4. PubMed ID: 8442250 [No Abstract] [Full Text] [Related]
37. The role of donor class I major histocompatibility complex peptides in the induction of allograft tolerance. Shirwan H; Mhoyan A; Leamer M; Wang C; Cramer DV Transplant Proc; 1997; 29(1-2):1134-5. PubMed ID: 9123235 [No Abstract] [Full Text] [Related]
38. An immunodominant minor histocompatibility alloantigen that initiates corneal allograft rejection. Haskova Z; Sproule TJ; Roopenian DC; Ksander AB Transplantation; 2003 Apr; 75(8):1368-74. PubMed ID: 12717232 [TBL] [Abstract][Full Text] [Related]
39. The role of indirect recognition of MHC class I and II allopeptides in a fully mismatched miniature swine model of lung transplantation. Sahara H; Shoji T; Ng CY; Weiss MJ; Muniappan A; Guenther DA; Houser SL; Pujara AC; Sayre JK; Wain JC; Sachs DH; Madsen JC; Allan JS Transplant Proc; 2006 Dec; 38(10):3256-8. PubMed ID: 17175241 [TBL] [Abstract][Full Text] [Related]
40. Preformed IgG antibodies against major histocompatibility complex class II antigens are major risk factors for high-grade cellular rejection in recipients of heart transplantation. Itescu S; Tung TC; Burke EM; Weinberg A; Moazami N; Artrip JH; Suciu-Foca N; Rose EA; Oz MC; Michler RE Circulation; 1998 Aug; 98(8):786-93. PubMed ID: 9727549 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]